COMMUNIQUÉS West-GlobeNewswire

Ensho Therapeutics Announces Upcoming Presentation at ECCO 2025 of Phase 1, Once-Daily Dosing Data for NSHO-101, an Oral α4β7 Inhibitor for Inflammatory Bowel Disease

14/02/2025 - 15:00

MORRIS PLAINS, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Ensho Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with [...]

Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025

14/02/2025 - 15:05

MIAMI, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

14/02/2025 - 15:15

ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS 14 FEBRUARY 2025 at 16.15 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]

AVITA Medical to Host Investor Webinar Briefing

14/02/2025 - 15:15

VALENCIA, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective [...]

Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity

14/02/2025 - 17:52

WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech company, today issued a statement from its Founder [...]

Zus Health Celebrates Unprecedented Growth, Announcing New Clients and AI-Powered Innovations

14/02/2025 - 18:33

BOSTON, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Zus Health is proud to announce a transformative milestone in its journey to reshape care delivery through data interoperability and actionable insights. Over the past year, Zus [...]

Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency

14/02/2025 - 19:16

WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech company, shares a summary of the Company’s 2024 [...]

PetVivo Reports Fiscal Q3 2025 Results

14/02/2025 - 21:10

MINNEAPOLIS, MN, US, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative therapeutics and medical devices for equines and companion [...]

Turmeric Hack: The 15-Second Morning Ritual Transforming Weight Loss, Backed by Doctor Julian Ross

14/02/2025 - 21:12

LAKELAND, Fla., Feb. 14, 2025 (GLOBE NEWSWIRE) -- A new, turmeric hack is rapidly reshaping the weight-loss conversation, offering a potential breakthrough for those who’ve tried (and failed) with traditional approaches [...]

New AI-Powered Startup Merges Technology and Holistic Wellness to Deliver Personalized Health Solutions

14/02/2025 - 21:45

New York, NY, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Samantha Williams , a professional runway and print magazine model for brands like Chi, today announced the launch of the waitlist for YOU Wellness, a new wellness [...]

MEDIA ADVISORY - Patients who have been extra-billed for surgeries in private for-profit clinics demand accountability in the Ontario election: Press conferences in towns across Ontario

14/02/2025 - 21:55

TORONTO, OTTAWA, LONDON and WINDSOR, Ontario, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The Ontario Health Coalition is holding press conferences with patients who have been charged for cataract surgeries or manipulated into [...]

Entero Therapeutics Appoints Richard Paolone as CEO

14/02/2025 - 22:00

BOCA RATON, Fla., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non- [...]

Fate Therapeutics to Present at Upcoming Investor Conferences

14/02/2025 - 22:01

SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

14/02/2025 - 22:01

SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]

NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation

14/02/2025 - 22:03

TORONTO and HAIFA, Israel, Feb. 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (“ NurExone ” or the “ Company ”) is excited to announce that it will be presenting at the [...]

Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference

14/02/2025 - 22:05

- Data from DELIVER and ACHIEVE Clinicals Trial to be Presented - - Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on the Use of Splicing Correction as a Prognostic Biomarker of Functional [...]

GENFIT annonce la modification des termes définitifs de la double proposition aux porteurs d’OCEANEs 2025

14/02/2025 - 22:10

Pour faire suite (i) à son annonce du 30 janvier 2025 sur l’accord de financement non dilutif de partage de redevances ( royalty financing ) avec HealthCare Royalty (HCRx) et (ii) à son annonce des termes définitifs de [...]

GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders

14/02/2025 - 22:10

In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, and (ii) the final terms of the dual proposal to the 2025 OCEANEs holders announced on February 10, 2025, [...]

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

14/02/2025 - 22:15

TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported [...]